Similar articles

Abstract: Objective: To study the expression level of TRF1 (telomeric repeat binding factor 1) protein in human acute leukemia and relationship between expression level of TRF1 protein and telomerase. Methods: A quantitative Western-Blot technique was developed using anti-TRF1^33-277 monoclonal antibody and GST-TRF1 purity protein as a standard to further determine the expression level of TRF1 protein in total proteins extracted from clinical specimens. Results: Bone marrow tissues of 20 acute leukemia patients were studied, 11 healthy donors’ bone marrows were taken as a control. The expression level of TRF1 protein was significantly higher (P<0.01) in normal bone marrow ((2.217±0.462) µg/µl) than that of acute leukemia patients ((0.754±0.343) µg/µl). But there was no remarkable difference between ALL and ANLL patients ((0.618±0.285) µg/µl vs (0.845±0.359) µg/µl, P>0.05). After chemotherapy, TRF1 expression level of patients with complete remission elevated ((0.772±0.307) µg/µl vs (1.683±0.344) µg/µl, P<0.01), but lower than that of normal ((2.217±0.462) µg/µl, P<0.01). There was no significantly difference after chemotherapy ((0.726±0.411) µg/µl vs (0.895±0.339) µg/µl, P>0.05). TRF1 expression level of patients with complete remission is higher than that of patients without complete remission ((1.683±0.344) µg/µl vs (0.895±0.339) µg/µl, P<0.01). All samples were determined for telomerase activity. It was confirmed that the activity of telomerase in normal bone marrow was lower than that of acute leukemia patients ((0.125±0.078) µg/µl vs (0.765±0.284) µg/µl, P<0.01). There was no significant difference of expression level of TRF1 protein between ALL and ANLL patients ((0.897±0.290) µg/µl vs (0.677±0.268) µg/µl, P>0.05). After chemotherapy, telomerase activity of patients with complete remission decreased ((0.393±0.125) µg/µl), but was still higher than that of normal ((0.125±0.078) µg/µl, P<0.01). Conclusion: The expression level of TRF1 protein has correlativity to the activity of telomerase (P<0.001).

[1] Aragona, M., Buda, C.A., Panetta, S., Morelli, M., Giudice, A., Campagna, F.L., Pontoriero, A., Cascinu, S., La Torre, F., 2000. Immunohistochemical telomeric-repeat binding factor-1 expression in gastrointestinal tumors. Oncol. Rep., 7(5):987-990.

[2] Aragona, M., de Divitiis, O., La Torre, D., Panetta, S., D′Avella, D., Pontoriero, A., Morell, M., La Torre, I., Tomasello, F., 2001. Immunohistochemical TRF1 expression in human primary intracranial tumors. Anticancer Res., 21(3C):2135-2139.

[3] Hiayma, E., Kodama, T., Shinbara, K., Iwao, T., Itoh, M., Hiyama, K., Shay, J.W., Matsuura, Y., Yokoyama, T., 1997. Telomease activity is detected in pancreatic cancer but not in benign tumors. Cancer Res., 57(2):326-331.

[4] Huang, H., Chen, Q.F., Lin, M.F., 2000. Cloning and high level expression of telomeric repeat binging factor 1 33-277 in Escherichia coli. Journal of Zhejiang University (Medical Sciences), 29(5):193-194 (in Chinese).

[5] Huang, H., Shi, J.M., Chen, Q.F., Luo, Y., Ding, W., Lou, J., 2002. Preparation and characterization of monoclonal antibody against human telomeric repeat binding factor 1. Chinese Journal of Hematology, 23(12):629-631 (in Chinese).

[6] La Torre, D., de Divitiis, O., Conti, A., Angileri, F.F., Cardali, S., Aguennouz, M., Aragona, M., Panetta, S., D′Avella, D., Vita, G., et al., 2005. Expression of telomeric repeat binding factor-1 in astroglial brain tumors. Neurosurgery, 56(4):802-810.

[7] Luo, J., Bosy, T.Z., Wang, Y., Yasuda, R.P., Wolfe, B.B., 1996. Ontogeny of NMDA R1 subunit protein expression in five regions of rat brain. Developmental Brain Research, 92(1):10-17.

[8] Ohyashiki, J.H., Hayashi, S., Yahata, N., Iwama, H., Ando, K., Tauchi, T., Ohyashiki, K., 2001. Impaired telomere regulation mechanism by TRF1 (telomere-binding protein), but not TRF2 expression, in acute leukemia cells. Int. J. Oncol., 18:593-598.

[9] van Steensel, B., de Large, T., 1997. Control of telomere length by the human telomeric protein TRF1. Nature, 385(6618):740-743.

[10] Yamada, K., Yajima, T., Yagihashi, A., Kobayashi, D., Koyanagi, Y., Asanuma, K., Yamada, M., Moriai, R., Kameshima, H., Watanabe, N., 2000. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells. Jpn. J. Cancer Res., 91(12):1278-1284.